Apax buys pharma business Neuraxpharm

The sellers are investment companies controlled by family office Strüngmann.

Apax stated its plan with the company, apart from organic growth, is to consolidate the European generic medicines market. As part of this strategy, it recently acquired Spanish business Invent Farma.

The firm held the first close for its ninth buyout fund, Apax IX, on $7bn in May this year.

Company
Founded in 1985, Neuraxpharm Arzneimittel is a pharmaceutical business, producing generic medicines in the area of central nervous system indications. It has 80 active substances in 280 pharmaceutical forms. Neuraxpharm is located in Langenfeld, near Dusseldorf, employs 100 people and has a turnover of €90m.

People
Apax Partners – Steven Dyson (partner, co-head of healthcare).
Atax – Thomas Strüngmann (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Healthcare
• Germany
• Apax Partners